[go: up one dir, main page]

Lu et al., 2004 - Google Patents

ICOS/B7RP-1 MODULATING SUBSTANCES IN A MOUSE MODEL OF KIDNEY TRANSPLANTATION

Lu et al., 2004

Document ID
1729980111907757918
Author
Lu R
Lutz J
Wang M
Ouyang N
Yoshinaga S
Heemann U
Publication year
Publication venue
Transplantation

External Links

Snippet

Aims: T-cells play a crucial role in inflammatory responses in renal allograft rejection. They are activated by binding of the T-cell receptor to alloantigenic peptides within the MHC II molecule of the antigen presenting cell and costimulation through receptors of the CD28 …
Continue reading at journals.lww.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Zhao et al. Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus
Kumashiro et al. Isolation of hepatocyte-like cells from mouse embryoid body cells
Bos et al. RENAL EXPRESSION OF HEAT-SHOCK PROTEINS AFTER BRAIN DEATH INDUCTION IN RATS
Grubic et al. THE EVALUATION OF MIXED CHIMERISM IN BONE MARROW TRANSPLANTATION PROGRAM IN CROATIA
Hsu et al. Enhancing islet engraftment with rosiglitazone
Interewicz et al. DNA RELEASED FROM REJECTING ORGANS IS AN INDICATOR OF THE DEGREE OF GRAFTCELLULAR DAMAGE
Gotoh et al. Ultrasound-mediated nonviral ex vivo gene transfer into liver graft
Hu et al. Surveillance Of Acute Rejection In Baboon Renal Transplantation By Elevation Of Ip-10 And Mig In Urine
Lu et al. ICOS/B7RP-1 MODULATING SUBSTANCES IN A MOUSE MODEL OF KIDNEY TRANSPLANTATION
Witkowski et al. EFFECT OF STREPTAVIDIN ON CARDIAC ALLOGRAFT PROLONGATION IS DUE TO HOST T CELL SUPPRESSION.
Suzuki et al. A NONVIRAL GENE TRANSFER USING THE ULTRASOUND-MICROBUBBLE METHOD HAS ENHANCED TRANSFECTION EFFICIENCY OF NF-κB DECOY INTO MURINE CARDIAC ALLOGRAFTS
Brandacher et al. INHIBITION OF THE IMMUNOMODULATORY ENZYME INDOLEAMINE 2, 3–DIOXYGENASE ACCELERATES ALLOGRAFT REJECTION.
Sarvary et al. MUTATION SCANNING OF THE P53 TUMOR SUPRESSOR GENE IN RENAL AND LIVER TRANSPLANTED PATIENTS IN HUNGARY
Kramer et al. ES CELL-DERIVED RENAL CELL TYPES: A TOOL FOR TISSUE REGENERATION?
Jorga et al. GENETIC CONTROL OF CICLOSPORIN ABSORPTION
Akiyoshi et al. SEROTONIN RECEPTOR ANTAGONIST INDUCES INDEFINITE SURVIVAL OF FULLY-ALLOGENEIC CARDIAC GRAFTS.
Koch et al. CHRONIC ALLOGRAFT NEPHROPATHY IN A RAT MODEL WITH COMPLETE MHC MISMATCH: EFFECTS OF THERAPEUTIC TREATMENT WITH FTY 720
Shimizu et al. COMBINATION THERAPY OF KRP-203, A NOVEL SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST, WITH CYCLOSPORINE ABROGATES ACUTE REJECTION WITHOUT ADVERSE EFFECTS–A COMPARATIVE STUDY WITH FTY720–
Yamamoto et al. FK778 CONTROL ACUTE REJECTION AFTER RAT LIVER ALLOTRANSPLANTATION INTERACTING WITH FK506 POSITIVELY
Suleiman et al. FTY720 TREATMENT PREVENTS RENAL T CELL INFILTRATION AFTER ISCHEMIA-REPERFUSION (I/R) INJURY.
Ding et al. Urinary cell messenger RNA profiles predict allograft outcome in patients with BKV nephropathy
Bueno et al. FTY720 DOES NOT PREVENT MESANGIAL CELL ACTIVATION BUT IMPAIRS NECROSIS DEVELOPMENT AFTER ISCHEMIA-REPERFUSION (I/R) INJURY.
Savikko et al. The Effect Cyclosporine on Chronic Allograft Changes in Syngenic Kidney Transplants
Vampa et al. NK CELLS ARE PREDOMINANT SOURCE OF γIFN: INHIBITION BY CYCLOSPORINE, TACROLIMUS, MMF, STEROID AND AZATHIOPRINE
Pühler et al. THE ROLE OF MYCOPHENOLATE MOFETIL IN THE PREVENTION OF CHRONIC REJECTION AFTER ALLOGENEIC LUNG TRANSPLANTATION IN RATS